# Bioavailability of EPA/DHA in of Ruby-O and Krill Oil

> **NCT05438173** · NA · COMPLETED · sponsor: **Midwest Center for Metabolic and Cardiovascular Research** · enrollment: 28 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DIETARY_SUPPLEMENT:** EPA + DHA Ruby-O
- **DIETARY_SUPPLEMENT:** EPA + DHA Krill Oil

## Key facts

- **NCT ID:** NCT05438173
- **Lead sponsor:** Midwest Center for Metabolic and Cardiovascular Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-11
- **Primary completion:** 2022-09-18
- **Final completion:** 2022-09-18
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05438173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05438173, "Bioavailability of EPA/DHA in of Ruby-O and Krill Oil". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05438173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*